Matches in SemOpenAlex for { <https://semopenalex.org/work/W2921767729> ?p ?o ?g. }
- W2921767729 endingPage "514" @default.
- W2921767729 startingPage "507" @default.
- W2921767729 abstract "Abstract Purpose We aimed to evaluate the efficacy and safety of rivaroxaban in thromboprophylaxis compared with those of aspirin in real‐world patients who underwent hip arthroplasty using nationwide claims data. Methods Patients aged more than or equal to 18 years with at least one hip arthroplasty including total and partial hip replacements and hip replacement revisions during July 2009 to June 2013 were identified from the Health Insurance Review and Assessment (HIRA) database. The study outcome was incidence rate of thromboembolic events and anticoagulation‐related major bleeding within 90 days of hip arthroplasty. Results The incidence of overall venous thromboembolism (VTE) within 90‐day postsurgery was significantly higher in the aspirin cohort than it was in the rivaroxaban cohorts. Bleeding events associated with pharmacological thromboprophylaxis in patients who received rivaroxaban were not significantly different from that in aspirin‐treated patients. In aspirin cohorts, 65.7% of patients received less than 3‐week treatment while about half received a less than 14‐day treatment, and 31.7% received more than 3‐week treatment in the rivaroxaban cohort. Conclusions This study demonstrates that rivaroxaban was more effective in preventing VTE following hip arthroplasty without raising bleeding risks in clinical settings. Age more than or equal to 80 years, women, and a history of thromboembolism were the risk factors of VTE incidence." @default.
- W2921767729 created "2019-03-22" @default.
- W2921767729 creator A5004277197 @default.
- W2921767729 creator A5016368526 @default.
- W2921767729 creator A5038945896 @default.
- W2921767729 creator A5051933063 @default.
- W2921767729 creator A5061227967 @default.
- W2921767729 creator A5075921544 @default.
- W2921767729 date "2019-03-07" @default.
- W2921767729 modified "2023-09-28" @default.
- W2921767729 title "Clinical outcomes and risk factors of thromboprophylaxis with rivaroxaban versus aspirin in patients undergoing hip arthroplasty in low‐incidence population: A nationwide study in Korea" @default.
- W2921767729 cites W1784033246 @default.
- W2921767729 cites W1966061797 @default.
- W2921767729 cites W1976604292 @default.
- W2921767729 cites W1988728763 @default.
- W2921767729 cites W2000984328 @default.
- W2921767729 cites W2013750247 @default.
- W2921767729 cites W2054001622 @default.
- W2921767729 cites W2071058513 @default.
- W2921767729 cites W2075215741 @default.
- W2921767729 cites W2111635289 @default.
- W2921767729 cites W2117198739 @default.
- W2921767729 cites W2149273974 @default.
- W2921767729 cites W2224587759 @default.
- W2921767729 cites W2273765516 @default.
- W2921767729 cites W2332034563 @default.
- W2921767729 cites W2345383514 @default.
- W2921767729 cites W2494072868 @default.
- W2921767729 cites W2617202428 @default.
- W2921767729 cites W2788601536 @default.
- W2921767729 cites W3016782834 @default.
- W2921767729 doi "https://doi.org/10.1002/pds.4737" @default.
- W2921767729 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30848013" @default.
- W2921767729 hasPublicationYear "2019" @default.
- W2921767729 type Work @default.
- W2921767729 sameAs 2921767729 @default.
- W2921767729 citedByCount "2" @default.
- W2921767729 countsByYear W29217677292020 @default.
- W2921767729 countsByYear W29217677292021 @default.
- W2921767729 crossrefType "journal-article" @default.
- W2921767729 hasAuthorship W2921767729A5004277197 @default.
- W2921767729 hasAuthorship W2921767729A5016368526 @default.
- W2921767729 hasAuthorship W2921767729A5038945896 @default.
- W2921767729 hasAuthorship W2921767729A5051933063 @default.
- W2921767729 hasAuthorship W2921767729A5061227967 @default.
- W2921767729 hasAuthorship W2921767729A5075921544 @default.
- W2921767729 hasConcept C120665830 @default.
- W2921767729 hasConcept C121332964 @default.
- W2921767729 hasConcept C126322002 @default.
- W2921767729 hasConcept C141071460 @default.
- W2921767729 hasConcept C201903717 @default.
- W2921767729 hasConcept C23276603 @default.
- W2921767729 hasConcept C2426938 @default.
- W2921767729 hasConcept C2776301958 @default.
- W2921767729 hasConcept C2776348710 @default.
- W2921767729 hasConcept C2777628954 @default.
- W2921767729 hasConcept C2778336525 @default.
- W2921767729 hasConcept C2778661090 @default.
- W2921767729 hasConcept C2779161974 @default.
- W2921767729 hasConcept C2780868729 @default.
- W2921767729 hasConcept C2991741193 @default.
- W2921767729 hasConcept C61511704 @default.
- W2921767729 hasConcept C71924100 @default.
- W2921767729 hasConcept C72563966 @default.
- W2921767729 hasConcept C98274493 @default.
- W2921767729 hasConceptScore W2921767729C120665830 @default.
- W2921767729 hasConceptScore W2921767729C121332964 @default.
- W2921767729 hasConceptScore W2921767729C126322002 @default.
- W2921767729 hasConceptScore W2921767729C141071460 @default.
- W2921767729 hasConceptScore W2921767729C201903717 @default.
- W2921767729 hasConceptScore W2921767729C23276603 @default.
- W2921767729 hasConceptScore W2921767729C2426938 @default.
- W2921767729 hasConceptScore W2921767729C2776301958 @default.
- W2921767729 hasConceptScore W2921767729C2776348710 @default.
- W2921767729 hasConceptScore W2921767729C2777628954 @default.
- W2921767729 hasConceptScore W2921767729C2778336525 @default.
- W2921767729 hasConceptScore W2921767729C2778661090 @default.
- W2921767729 hasConceptScore W2921767729C2779161974 @default.
- W2921767729 hasConceptScore W2921767729C2780868729 @default.
- W2921767729 hasConceptScore W2921767729C2991741193 @default.
- W2921767729 hasConceptScore W2921767729C61511704 @default.
- W2921767729 hasConceptScore W2921767729C71924100 @default.
- W2921767729 hasConceptScore W2921767729C72563966 @default.
- W2921767729 hasConceptScore W2921767729C98274493 @default.
- W2921767729 hasIssue "4" @default.
- W2921767729 hasLocation W29217677291 @default.
- W2921767729 hasLocation W29217677292 @default.
- W2921767729 hasOpenAccess W2921767729 @default.
- W2921767729 hasPrimaryLocation W29217677291 @default.
- W2921767729 hasRelatedWork W2173903304 @default.
- W2921767729 hasRelatedWork W2320301988 @default.
- W2921767729 hasRelatedWork W2523006498 @default.
- W2921767729 hasRelatedWork W2542248393 @default.
- W2921767729 hasRelatedWork W2595086780 @default.
- W2921767729 hasRelatedWork W2767235320 @default.
- W2921767729 hasRelatedWork W2921767729 @default.
- W2921767729 hasRelatedWork W2978156863 @default.
- W2921767729 hasRelatedWork W4238945033 @default.